Title: Use of Mineral Trioxide Aggregate For Apexification Treatment, Literature Review

Abstract:

Mineral Trioxide Aggregate (MTA) was first introducted by Mahmoud Torabinejad at Loma Linda University, California, USA in 1993 and inaugurated in 1998 by US Food and Drug Administration. Use of MTA in the apexification treatment to young treatment teeth that have to protect the pulp necrosis resulting in the closure of the apical tip of the good that is not contamited with bacteria. MTA has a good biocompatible and an antimicrobial barriers because that is formed on the apical calcification. The success of this treatment can be checked with a probe or endo files and radiographys after 6 months. The signs of success is reduced inflammatory reaction, a reaction occurs that new odontoblast mineralization so that the closure of calcified barrier. This is evident, the success of the apical barrier formation of 94.1% and 76.5% and 17.6% closures is unknown circumstances. From this the conclusion, apicl closure care have short time to reduce the multivisit care complications and reduce the risk of fracture as well.

Biography:

Mervi Chandra has completed her Dentist at the age of 25 years from Trisakti University in 2012 and master’s degree studies magister management of Business & economic’s sustainability at the age of 29 years from Trisakti University in 2018. She is the dentist of PT. Kimia farma district Pos Pengumen Raya, West Jakarta and doctor teleconsultation in Halodoc Healcare’s Digital company and PDGI (Persatuan Kedokeran Gigi Indonesia) organization. She has published more than 2 papers in reputed journals and has been serving as an editorial board member of repute in Trisakti University.